Monitor for any subsequent filings regarding board appointments or changes in governance strategy. Given the lack of controversy and the non-executive nature of the role, this departure is unlikely to affect stock price or company operations.
Price Chart
Executive Summary
Gaurav Aggarwal, a director of Unicycive Therapeutics, Inc., resigned from the Board of Directors effective April 6, 2026. The resignation was not due to any disagreement with the company, and no replacement was named. This is a routine board change with no immediate operational or financial implications.
Key Facts
- Dr. Gaurav Aggarwal resigned from the Board of Directors of Unicycive Therapeutics (UNCY) effective April 6, 2026
- The resignation was not the result of any disagreement with the company or its management
- The company expressed gratitude for his service
- No replacement was named in the filing
- This was a non-executive board member departure, not a C-suite or CEO/CFO exit
Financial Impact
No direct financial impact disclosed
Risk Factors
- Potential loss of strategic guidance if Dr. Aggarwal played a key advisory role
- Perception of board instability if additional departures follow
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-040179 |
| Document: 0001213900-26-040179-index-headers.html | 0001213900-26-040179 |
| Document: 0001213900-26-040179-index.html | 0001213900-26-040179 |
| Document: 0001213900-26-040179.txt | 0001213900-26-040179 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 25d ago | 3 | $4.22 | awaiting T+60 | — | $3.61 (−14.57%) |
Sep 29, 2026 28d ago | 8-K | $4.55 | awaiting T+60 | — | $3.61 (−20.77%) |
Aug 12, 2026 10w ago | 8-K | $5.39 | awaiting T+60 | — | $3.61 (−33.12%) |
Jul 2, 2026 16w ago | 8-K | $5.73 $4.81 | ▼ −16.06% | ▼ −19.06% | $3.61 (−37.09%) |
Jun 22, 2026 18w ago | DEFA14A | $7.87 $4.71 | ▼ −40.15% | ▼ −41.90% | $3.61 (−54.19%) |
Jun 16, 2026 19w ago | EFFECT | $7.17 $5.31 | ▲ +25.94% | ▲ +26.94% | $3.61 (+49.72%) |
Jun 5, 2026 20w ago | S-3 | $6.66 $5.05 | ▲ +24.17% | ▲ +27.23% | $3.61 (+45.87%) |
May 12, 2026 24w ago | 8-K | $8.17 $5.05 | ▼ −38.19% | ▼ −42.57% | $3.61 (−55.88%) |
May 12, 2026 24w ago | Press Release | $8.17 $5.05 | ▲ +38.19% | ▲ +42.57% | $3.61 (+55.88%) |
Apr 6, 2026 29w ago | 8-K | $6.62 $5.28 | ▼ −20.24% | ▼ −33.71% | $3.61 (−45.54%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers